Connect with us

Hi, what are you looking for?

News

Ivermectin Reduces Covid Death Risk by 92%, Peer-Reviewed Study Finds

A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

The large study was conducted by Flávio A. Cadegiani, MD, MSc, PhD. Cadegiani is a board-certified endocrinologist with a master’s degree and doctorate degree in clinical endocrinology.

The peer-reviewed study was published on Wednesday by the online medical journal Cureus. The study was conducted on a strictly controlled population of 88,012 people from the city of Itajaí in Brazil.

Individuals who used ivermectin as prophylaxis or took the medication before being infected by COVID experienced significant reductions in death and hospitalization.

According to the study, those who took ivermectin regularly had a 92% reduction in their COVID death risk compared to non-users and 84% less than irregular users.

“The hospitalization rate was reduced by 100% in regular users compared to both irregular users and non-users,” the study stated.

The impressive reduction for regular ivermectin users was evident despite the regular users being at a higher risk for COVID deaths. The regular users were older and had a higher prevalence of type 2 diabetes and hypertension than irregular and non-users.

Irregular users of ivermectin had a 37% lower mortality rate reduction than non-users.

The study defined regular users as those who used more than 30 tablets of ivermectin over five months. The dosage of ivermectin was determined by body weight, but “most of the population used between two and three tablets daily for two days, every 15 days.”

“Non-use of ivermectin was associated with a 12.5-fold increase in mortality rate and a seven-fold increased risk of dying from COVID-19 compared to the regular use of ivermectin,” the study read. “This dose-response efficacy reinforces the prophylactic effects of ivermectin against COVID-19.”

Cadegiani believes the study showed a “dose-response effect” – which means that increasing levels of ivermectin decreased the risk of hospitalization and death from COVID-19.

Cadegiani wrote on Twitter, “An observational study with the size and level of analysis as ours is hardly achieved and infeasible to be conducted as a randomised clinical trial. Conclusions are hard to be refuted. Data is data, regardless of your beliefs.”

READ 29 COMMENTS
  • sandy says:

    How sad for those who died. They did not even give them a chance to live.

  • James Daniel says:

    But didn’t the omniscience God of science, Fauci say it didn’t work?

  • Rita says:

    This was known early on and even now doctors are harassed and investigated who prescribe it. Pharmacies are refusing to fill it. How sick has this country and the medical profession become that they had rather save their butts than keep people from dying?

  • Scurvydog says:

    Yet, Fauci and his lackeys did everything in their power to prevent ivermectin’s use. That tells me all I need to know about Fauci…

  • TOP STORIES

    News

    President Joe Biden introduced Ukrainian President Volodymyr Zelensky as ‘President Putin’ in a brutal gaffe at the NATO summit with his political future hanging...

    News

    What isn’t scripted about this presidency? It’s part of the reason why so many in liberal America got gutted during the June 27 debate....

    News

    Journalists, already frustrated with the White House’s evasive responses to inquiries about Joe Biden’s health and mental acuity, are gearing up for another whirlwind...

    News

    It’s been six months since three Kansas City Chiefs fans were found dead in a friend’s backyard after gathering to watch their favorite football...

    >